F-0463-2024 Class III Terminated

Recalled by ActiPharma, Inc. — Guaynabo, PR

FDA food recall F-0463-2024 was initiated by ActiPharma, Inc. on Sep 28, 2023 and is designated Class III. Reason for recall: FDA sample analysis of ACTIRON Dietary Supplement, 100 Tablets, Lot 13309, found the product did not meet folic acid specification compared to the label claim. The recall status is terminated (terminated Jan 16, 2024). Affected quantity: 607 bottles of 100 tablets each.

Recall details

Product Type
Food
Report Date
Nov 29, 2023
Initiation Date
Sep 28, 2023
Termination Date
Jan 16, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
607 bottles of 100 tablets each

Product description

ACTIRON Dietary Supplement, ActiPharma, 100 tablets (24 bottles per case) ) (Lot 13309, Exp.: 01/26), UPC: 363102217104.

Reason for recall

FDA sample analysis of ACTIRON Dietary Supplement, 100 Tablets, Lot 13309, found the product did not meet folic acid specification compared to the label claim.

Distribution pattern

Domestic distribution, in Puerto Rico.

Code information

Lot 13309, Exp: 01/26

Source

Dataset
openFDA food recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for F-0463-2024
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 15, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for F-0463-2024. Report a data issue: hello@regdatalab.com.